Viewing Study NCT05911360


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-26 @ 12:27 AM
Study NCT ID: NCT05911360
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
Sponsor: ViiV Healthcare
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-31
Start Date Type: ACTUAL
Primary Completion Date: 2025-02-24
Primary Completion Date Type: ACTUAL
Completion Date: 2026-01-13
Completion Date Type: ESTIMATED
First Submit Date: 2023-06-09
First Submit QC Date: None
Study First Post Date: 2023-06-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-27
Last Update Post Date: 2025-12-01
Last Update Post Date Type: ESTIMATED